Brief: Enlivex Says Israeli Ministry Of Health Authorizes Initiation Of Phase IIb Clinical Trial Evaluating Allocetra In Severe COVID-19 Patients

Enlivex

15/08/2021 11:05

Aug 15 (Reuters) - Enlivex Therapeutics Ltd  ENLV.TA :
    * ENLIVEX THERAPEUTICS - ISRAELI MINISTRY OF HEALTH
AUTHORIZES
INITIATION OF PHASE IIB CLINICAL TRIAL EVALUATING ALLOCETRA IN
SEVERE COVID-19 PATIENTS
    * ENLIVEX -PHASE IIB TRIAL EXPECTED TO RECRUIT UP TO 152
SEVERE OR
CRITICAL COVID-19 PATIENTS IN CLINICAL CENTERS IN ISRAEL &
CERTAIN EUROPEAN COUNTRIES
    * ENLIVEX THERAPEUTICS LTD - TRIAL TO ASSESS SAFETY AND
EFFICACY
OF ALLOCETRATM WHEN ADMINISTERED IN ADDITION TO STANDARD OF CARE
TREATMENT
    * ENLIVEX- TRIAL WILL HAVE TWO PRIMARY ENDPOINTS:
VENTILATION-FREE
SURVIVAL AND RECOVERY FOR EACH OF TWO SUB-POPULATIONS OF
PATIENTS IN STUDY
    * ENLIVEX THERAPEUTICS LTD - TRIAL WILL ASSESS SEVERAL
SECONDARY
ENDPOINTS, INCLUDING EVALUATION OF LONG-COVID-19 SYMPTOMS

Source text for Eikon:  ID:nGNX8dv3m8 
Further company coverage:  ENLV.TA 

 ((Reuters.Briefs@thomsonreuters.com;))